# Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)

> **NCT02585726** · NA · COMPLETED · sponsor: **Lake Washington Vascular** · enrollment: 50 (actual)

## Conditions studied

- Venous Reflux

## Interventions

- **DEVICE:** SP-402 VenaSeal™ Closure System

## Key facts

- **NCT ID:** NCT02585726
- **Lead sponsor:** Lake Washington Vascular
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02585726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02585726, "Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02585726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*